Sevoflurane Postconditioning Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting SP1/ACSL4-Mediated Ferroptosis
Human & Experimental Toxicology · 2023
DOI: 10.1177/09603271231160477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human & Experimental Toxicology, 2023. Verfasst von Ning Lyu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, 56659Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China. Hauptthemen laut MEDLINE: Brain Ischemia, Ferroptosis, Reperfusion Injury. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Sevoflurane is the most commonly used anesthetic in clinical practice and exerts a protective effect on cerebral ischemia-reperfusion (I/R) injury. This study aims to elucidate the molecular mechanism by which sevoflurane postconditioning protects against cerebral I/R injury. Oxygen-glucose deprivation/reperfusion (OGD/R) model in vitro and the middle cerebral artery occlusion (MCAO) model in vivo were established to simulate cerebral I/R injury. Sevoflurane postconditioning reduced neurological deficits, cerebral infarction, and ferroptosis after I/R injury. Interestingly, sevoflurane significantly inhibited specificity protein 1 (SP1) expression in MACO rats and HT22 cells exposed to OGD/R. SP1 overexpression attenuated the neuroprotective effects of sevoflurane on OGD/R-treated HT22 cells, evidenced by reduced cell viability, increased apoptosis, and cleaved caspase-3 expression. Furthermore, chromatin immunoprecipitation and luciferase experiments verified that SP1 bound directly to the ACSL4 promoter region to increase its expression. In addition, sevoflurane inhibited ferroptosis via SP1/ACSL4 axis. Generally, our study describes an anti-ferroptosis effect of sevoflurane against cerebral I/R injury via downregulating the SP1/ASCL4 axis. These findings suggest a novel sight for cerebral protection against cerebral I/R injury and indicate a potential therapeutic approach for a variety of cerebral diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, 56659Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China.
- Department of Anesthesiology, 144991The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Ning Lyu
Zitieren
APA
Lyu, N., & Li, X. (2023). Sevoflurane Postconditioning Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting SP1/ACSL4-Mediated Ferroptosis. Human & Experimental Toxicology. https://doi.org/10.1177/09603271231160477
Vancouver
Lyu N, Li X. Sevoflurane Postconditioning Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting SP1/ACSL4-Mediated Ferroptosis. Human & Experimental Toxicology. 2023. doi:10.1177/09603271231160477
BibTeX
@article{Lyu2023,
author = {Lyu, Ning and Li, Xiaoyun},
title = {Sevoflurane Postconditioning Attenuates Cerebral Ischemia-Reperfusion Injury by Inhibiting SP1/ACSL4-Mediated Ferroptosis},
journal = {Human & Experimental Toxicology},
year = {2023},
doi = {10.1177/09603271231160477}
}
EUVIMED